Ani Pharmaceuticals (ANIP) Selling, General & Administrative (2010 - 2026)
Ani Pharmaceuticals' Selling, General & Administrative was $91.66 million in Q2 2026, up 12.1% from $81.77 million a year earlier and up 24.4% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ani Pharmaceuticals' Selling, General & Administrative was $324.76 million through Jun 30, 2026, up 5.8% year-over-year; for FY2025, it was $317.75 million, up 27.3% from FY2024.
- Selling, General & Administrative has now increased for 16 consecutive years, with a five-year compound annual growth rate of 37.4% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $249.64 million in FY2024 (+54.4%), $161.7 million in FY2023 (+30.4%), $124.04 million in FY2022 (+47.2%) and $84.29 million in FY2021 (+29.7%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- Compared with a year earlier, Selling, General & Administrative was higher in six of the last eight quarters, with growth averaging 35.4%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2021 (growth of 113.8%); the worst was Q1 2026 (a decline of 3.8%).
- Per Business Quant data, ANIP's Selling, General & Administrative in the three quarters before Q2 2026 was $73.66 million (Q1 2026), $82.79 million (Q4 2025) and $76.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Ani Pharmaceuticals | 1.72 Bn | 502.13 Mn | 165.89 Mn | 91.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.66 Mn |
| Mar 31, 2026 | 73.66 Mn |
| Dec 31, 2025 | 82.79 Mn |
| Sep 30, 2025 | 76.66 Mn |
| Jun 30, 2025 | 81.77 Mn |
| Mar 31, 2025 | 76.53 Mn |
| Dec 31, 2024 | 69.72 Mn |
| Sep 30, 2024 | 79.08 Mn |
| Jun 30, 2024 | 52.82 Mn |
| Mar 31, 2024 | 48.02 Mn |
| Dec 31, 2023 | 44.46 Mn |
| Sep 30, 2023 | 42.01 Mn |
| Jun 30, 2023 | 38.76 Mn |
| Mar 31, 2023 | 36.47 Mn |
| Dec 31, 2022 | 33.19 Mn |
| Sep 30, 2022 | 30.08 Mn |
| Jun 30, 2022 | 31.96 Mn |
| Mar 31, 2022 | 28.82 Mn |
| Dec 31, 2021 | 30.71 Mn |
| Sep 30, 2021 | 17.18 Mn |
API Access
Ani Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();